Abpro Corporation (ABP)
ABP Stock Price Chart
Explore Abpro Corporation interactive price chart. Choose custom timeframes to analyze ABP price movements and trends.
ABP Company Profile
Discover essential business fundamentals and corporate details for Abpro Corporation (ABP) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
9 Mar 2022
Employees
6.00
Website
https://abpro.comCEO
Jin Wook Suk
Description
Abpro Holdings, Inc., a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues. Its platform DiversImmune addresses a bottleneck in the antibody therapeutics industry. Its lead product candidates include ABP-100 for the treatment of breast, gastric, and colorectal cancers; and ABP-201 for the treatment of vascular diseases of the eye. The company has a strategic partnership with Abpro Bio Co. Ltd and NJCTTQ. The company was formerly known as Abpro Corporation and changed its name to Abpro Holdings, Inc. in November 2024. Abpro Holdings, Inc. was incorporated in 2004 and is headquartered in Woburn, Massachusetts.
ABP Financial Timeline
Browse a chronological timeline of Abpro Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 13 Aug 2025
EPS came in at -$0.04 .
ABP Stock Performance
Access detailed ABP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.